Breaking News
May 3, 2019 - Vaping and Smoking May Signal Greater Motivation to Quit
May 3, 2019 - Dementia looks different in brains of Hispanics
May 3, 2019 - Short-Staffed Nursing Homes See Drop In Medicare Ratings
May 3, 2019 - Study of teens with eating disorders explores how substance users differ from non-substance users
May 3, 2019 - Scientists develop new video game that may help in the study of Alzheimer’s
May 3, 2019 - Arc Bio introduces Galileo Pathogen Solution product line at ASM Clinical Virology Symposium
May 3, 2019 - Cornell University study uncovers relationship between starch digestion gene and gut bacteria
May 3, 2019 - How to Safely Use Glucose Meters and Test Strips for Diabetes
May 3, 2019 - Anti-inflammatory drugs ineffective for prevention of Alzheimer’s disease
May 3, 2019 - Study tracks Pennsylvania’s oil and gas waste-disposal practices
May 3, 2019 - Creating a better radiation diagnostic test for astronauts
May 3, 2019 - Vegans are often deficient in these four nutrients
May 3, 2019 - PPDC announces seed grants to develop medical devices for children
May 3, 2019 - Study maps out the frequency and impact of water polo head injuries
May 3, 2019 - Research on Reddit identifies risks associated with unproven treatments for opioid addiction
May 3, 2019 - Good smells may help ease tobacco cravings
May 3, 2019 - Medical financial hardship found to be very common among people in the United States
May 3, 2019 - Researchers develop multimodal system for personalized post-stroke rehabilitation
May 3, 2019 - Study shows significant mortality benefit with CABG over percutaneous coronary intervention
May 3, 2019 - Will gene-editing of human embryos ever be justifiable?
May 3, 2019 - FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions
May 3, 2019 - Why Tonsillitis Keeps Coming Back
May 3, 2019 - Fighting the opioid epidemic with data
May 3, 2019 - Maggot sausages may soon be a reality
May 3, 2019 - Deletion of ATDC gene prevents development of pancreatic cancer in mice
May 2, 2019 - Targeted Therapy Promising for Rare Hematologic Cancer
May 2, 2019 - Alzheimer’s disease is a ‘double-prion disorder,’ study shows
May 2, 2019 - Reservoir bugs: How one bacterial menace makes its home in the human stomach
May 2, 2019 - Clinical, Admin Staff From Cardiology Get Sneak Peek at Epic
May 2, 2019 - Depression increases hospital use and mortality in children
May 2, 2019 - Vicon and NOC support CURE International to create first gait lab in Ethiopia
May 2, 2019 - Researchers use 3D printer to make paper organs
May 2, 2019 - Viral infection in utero associated with behavioral abnormalities in offspring
May 2, 2019 - U.S. Teen Opioid Deaths Soaring
May 2, 2019 - Opioid distribution data should be public
May 2, 2019 - In the Spotlight: “I’m learning every single day”
May 2, 2019 - 2019 Schaefer Scholars Announced
May 2, 2019 - Podcast: KHN’s ‘What The Health?’ Bye-Bye, ACA, And Hello ‘Medicare-For-All’?
May 2, 2019 - Study describes new viral molecular evasion mechanism used by cytomegalovirus
May 2, 2019 - SLU study suggests a more equitable way for Medicare reimbursement
May 2, 2019 - Scientists discover first gene involved in lower urinary tract obstruction
May 2, 2019 - Researchers identify 34 genes associated with increased risk of ovarian cancer
May 2, 2019 - Many low-income infants receive formula in the first few days of life, finds study
May 2, 2019 - Global study finds high success rate for hip and knee replacements
May 2, 2019 - Taking depression seriously: What is it?
May 2, 2019 - With Head Injuries Mounting, Will Cities Put Their Feet Down On E-Scooters?
May 2, 2019 - Scientists develop small fluorophores for tracking metabolites in living cells
May 2, 2019 - Study casts new light into how mothers’ and babies’ genes influence birth weight
May 2, 2019 - Researchers uncover new brain mechanisms regulating body weight
May 2, 2019 - Organ-on-chip systems offered to Asia-Pacific regions by Sydney’s AXT
May 2, 2019 - Adoption of new rules drops readmission penalties against safety net hospitals
May 2, 2019 - Kids and teens who consume zero-calorie sweetened beverages do not save calories
May 2, 2019 - Improved procedure for cancer-related erectile dysfunction
May 2, 2019 - Hormone may improve social behavior in autism
May 2, 2019 - Alzheimer’s disease may be caused by infectious proteins called prions
May 2, 2019 - Even Doctors Can’t Navigate Our ‘Broken Health Care System’
May 2, 2019 - Study looks at the impact on criminal persistence of head injuries
May 2, 2019 - Honey ‘as high in sugars as table sugar’
May 2, 2019 - Innovations to U.S. food system could help consumers in choosing healthy foods
May 2, 2019 - FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients
May 2, 2019 - Women underreport prevalence and intensity of their own snoring
May 2, 2019 - Concussion summit focuses on science behind brain injury
May 2, 2019 - Booker’s Argument For Environmental Justice Stays Within The Lines
May 2, 2019 - Cornell research explains increased metastatic cancer risk in diabetics
May 2, 2019 - Mount Sinai study provides fresh insights into cellular pathways that cause cancer
May 2, 2019 - Researchers to study link between prenatal pesticide exposures and childhood ADHD
May 2, 2019 - CoGEN Congress 2019: Speakers’ overviews
May 2, 2019 - A new strategy for managing diabetic macular edema in people with good vision
May 2, 2019 - Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance
May 2, 2019 - Screen time associated with behavioral problems in preschoolers
May 2, 2019 - Hormone reduces social impairment in kids with autism | News Center
May 2, 2019 - Researchers synthesize peroxidase-mimicking nanozyme with low cost and superior catalytic activity
May 2, 2019 - Study results of a potential drug to treat Type 2 diabetes in children announced
May 2, 2019 - Multigene test helps doctors to make effective treatment decisions for breast cancer patients
May 2, 2019 - UNC School of Medicine initiative providing unique care to dementia patients
May 2, 2019 - Nestlé Health Science and VHP join forces to launch innovative COPES program for cancer patients
May 2, 2019 - Study examines how our brain generates consciousness and loses it during anesthesia
May 2, 2019 - Transition Support Program May Aid Young Adults With Type 1 Diabetes
May 2, 2019 - Study shows how neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death
May 2, 2019 - Research reveals complexity of how we make decisions
The Brain Institute wins $7.04 million grant to investigate ‘neurophilosphy of free will’

The Brain Institute wins $7.04 million grant to investigate ‘neurophilosphy of free will’

The newly-minted Institute for Interdisciplinary Brain and Behavioral Science (The Brain Institute) at Chapman University, with Dr. Uri Maoz as project leader, is the recipient of a total of $7.04 million to study how the human brain enables conscious control of decisions and actions. The John Templeton Foundation funded $5.34 million; the Fetzer Institute funded $1.55 million; and the remaining $150,000 comes from the Fetzer Memorial Trust. This is Chapman’s largest non-federal research grant to date. With the Chapman Brain Institute serving as the central hub, this grant supports research efforts at 17 universities spanning four continents, including Charité Berlin (Germany), Dartmouth, Duke, Florida State University, Harvard, Indiana University Bloomington, NIH, Monash University (Australia), NYU, Sigtuna (Sweden), Tel Aviv University (Israel), University College London (UK), University of Edinburgh (UK), UCLA and Yale. The project launched at an international conference on the Neuroscience of Free Will that the Brain Institute and Crean College of Health and Behavioral Sciences at Chapman University hosted in mid-March.

“We were pleased to establish Chapman’s Brain Institute and to bring the faculty associated with it to Chapman University last year,” said Daniele Struppa, Ph.D., Chapman University president. “Their approach to research reflects Chapman’s goal of combining research with teaching and involving undergraduate and graduate students at all levels in the process. We are grateful for this grant from the Templeton Foundation and the Fetzer Institute, which recognizes Chapman as a leader in this developing field.”

“This grant aims to create a new field in the study of the brain–the neurophilosphy of free will,” said Uri Maoz, Ph.D., assistant professor of psychology and computational neuroscience at Chapman University. “The extent and scope of human free will has been debated by philosophers for millennia. In recent decades, neuroscientists have joined the discussion, leading to some interesting discoveries. The current project, however, represents a four-year effort forging structured, close collaborations on these questions between eight neuroscientists (including Dr. Aaron Schurger, assistant professor of psychology, the latest faculty recruit to the Brain Institute at Chapman) and nine philosophers from around the world. Hopefully, in 10 years we will look back at the grant and say that’s where it all started,” said Dr. Maoz.

“This large-scale investment, by the John Templeton Foundation and the Fetzer Institute, comes to the Brain Institute even before its official launch next month,” said Amir Raz, Ph.D., Chapman University professor of psychology and brain sciences and director of the Brain Institute. “Work at the Brain Institute addresses fundamental questions of human experience: do we have free will? Are we, in fact, free to do what we wish? What is the role of consciousness in our decisions? We are grateful for the opportunities the combined grant offers as well as the testament it provides to confidence in our work.”

“The Templeton Foundation and Fetzer Institute grant acknowledge that consequential, complex questions find answers only when approached through the lenses of multiple disciplines and their research techniques,” said Janeen Hill, Ph.D., dean of Crean College. “Chapman University and Crean College’s commitment to brain science and its inherent interdisciplinarity is reinforced by the significance of this combined grant.”

Entitled “Consciousness and Free Will: A Joint Neuroscientific-Philosophical Investigation,” the grant aims to advance efforts in the neurophilosphy of free will. For example, researchers at the Brain Institute and their collaborators will use advanced analysis techniques of brain activity and strive to decode decisions and actions before they take place. Or they will use various techniques to compare human brain activity when people make arbitrary decisions (e.g., when asked to randomly raise their left or right hand) and deliberate ones (e.g., when asked to raise their left or right hand to donate to one charity or another).

“This grant, placing Chapman as a leader in neuroscience, reflects our deepening commitment to research and to academic excellence,” said Glenn Pfeiffer, Ph.D., provost of Chapman University. “This announcement comes soon after the recent elevation of Chapman University to Carnegie Classification R2, signifying ‘high research activity.’ We have never been stronger as a research institution than we are right now.”

“In fact,” said Thomas Piechota, Ph.D., PE, vice president of research, “this is an opportune time to partner with Chapman University. The research being conducted by the Brain Institute and throughout Chapman is exciting and innovative. Our faculty are exemplary researchers and the involvement of students of every level – including first-year undergraduates – is a fundamental part of the personalized education that we offer.”

Hosted at the Rinker Health Science campus in Irvine, as well as on the Orange campus, the Brain Institute comprises a network of interdisciplinary researchers who conduct empirical investigations into the cognitive neuroscience of altered planes of consciousness, neuropsychology, volition, formal models of higher brain functions among other fields. Our work draws on clinical populations, healthy volunteers, and innovations in artificial intelligence, machine learning, and big data.

“Questions about consciousness and free will are of enduring interest in both philosophy and the sciences. This project will feature field-leading researchers on these two topics, using rigorous and collaborative methods to advance our understanding of both of them. It is therefore a perfect fit for the John Templeton Foundation, and we are pleased to support Chapman in this initiative,” said John Churchill, director of philosophy and theology programs at the John Templeton Foundation.

“We are drawn to this work because of its cutting-edge exploration of free will, the breadth of the research effort Chapman University has developed, and the scale of this major funding collaboration with Templeton,” said Mohammed Mohammed, Fetzer Institute program director of research, discovery, and development. “We are excited about this venture into the intersection of philosophy and neuroscience.”

Tagged with:

About author

Related Articles